If at first the idea is not absurd, then there is no hope for it.

Think about this: plants see you.

Anyone talking to you,
and avoiding your sight
Is someone that towards you,
their intentions aren't right.

Sometimes seeing everything just gets in the way.

With Rupayan Banerjee

Learn to be alone and to like it. There is nothing more empowering or freeing than learning to like your own company.

It will be always u

When you need to jump over hardles you got to. Life is all about that .

Regenerative Medicine Market is Growing Quickly : Here's What You Need To Know By 2030

Read More: https://www.emergenresearch.co....m/industry-report/re

The global Regenerative Medicine (RM) market size was USD 9,800.00 Million in 2021 and is expected to register a revenue CAGR of 15.9% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of chronic diseases, such as cancer, Cardiovascular Diseases (CVD), and diabetes is a major factor driving market revenue growth.

The U.S. Food and Drug Administration (FDA) has approved regenerative medicines for a number of diseases, including melanoma, prostate cancer, damaged cartilage, lymphomas, spinal muscular atrophy, and Leber congenital amaurosis, among others. In 2022, over 15 stem cell therapies have been approved by FDA in 2022, which is expected to address a broad range of diseases, thereby rising demand for regenerative medicines among patients over the coming years and driving revenue growth of the regenerative medicines market.

Next Generation Sequencing Market Size, Revenue Analysis, PEST, Region & Country Forecast, 2030

Read More: https://www.emergenresearch.co....m/industry-report/ne

The global Next Generation Sequencing Market is expected to reach USD 23.59 Billion by 2027, according to a new report by Emergen Research. The benefits of high-performance sequencing compared to other generations, such as the sanger-seq and microarrays, are one of the main drivers of the Next Generation Sequencing (NGS) industry. Therefore, it is expected that the increased availability of low input DNA sampling methods would speed up the use of next-generation sequence across various clinical and research applications.

New England Biolabs Technology that uses magnetic beads in the prototype assembly process is expected to boost next-generation sample preparedness protocols significantly. Moreover, the dropping costs and the added value of next-generation sequencing data relative to traditional data are anticipated to have a positive impact on this technology's diversification in other clinical areas and result in lucrative revenue growth.